Jump to content

Cinchophen

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DePiep (talk | contribs) at 13:23, 2 April 2016 (Remove redundant parameters InChI, InChIKey (using StdInChI, StdInChIKey). See Talk (via AWB script)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Cinchophen
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
  • 2-phenylquinoline-4-carboxylic acid
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.004.608 Edit this at Wikidata
Chemical and physical data
FormulaC16H11NO2
Molar mass249.264 g/mol g·mol−1
3D model (JSmol)
  • O=C(O)c1c3ccccc3nc(c1)c2ccccc2
  • InChI=1S/C16H11NO2/c18-16(19)13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H,(H,18,19) checkY
  • Key:YTRMTPPVNRALON-UHFFFAOYSA-N checkY
  (verify)

Cinchophen (trade names Atophan, Quinophan, and Phenaquin) is an analgesic drug that was introduced in 1910 and frequently used to treat gout. This drug is still used, in combination with Prednisolone, by veterinarians to treat arthritis in animals.

Use of this drug in humans ceased in the 1930s due to the discovery that cinchophen can cause serious liver damage.[1]

There is some evidence that it stimulates C-Fos.[2]

References

  1. ^ Cutrín Prieto C, Nieto Pol E, Batalla Eiras A, Casal Iglesias L, Pérez Becerra E, Lorenzo Zúñiga V (1991). "[Toxic hepatitis from cinchophen: report of 3 cases]". Medicina clínica (in Spanish). 97 (3): 104–6. PMID 1679861.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. ^ Takayama K, Xiong Y, Miura M (May 1994). "Neuronal expression of Fos protein in the paraventricular nucleus of the hypothalamus after i.p. injection of ulcergenic cinchophen". Neurosci. Lett. 172 (1–2): 55–8. doi:10.1016/0304-3940(94)90661-0. PMID 7916144.{{cite journal}}: CS1 maint: multiple names: authors list (link)